Browsing by Author "Inna Grynevych"

Filter results by typing the first few letters
Now showing 1 - 2 of 2
  • No Thumbnail Available
    Item
    Hepatobiliary System Lesions in Children with COVID-19. Literature Review and Own Observations
    (ECronicon, 2022-06-30) Sergiy Kramarov; Iryna Seriakova; Vitalii Yevtushenko; Liudmyla Palatna; Iryna Shpak; Valerii Shadrin; Nataliia Kyrytsia; Mariia Dudnikova; Hanna Zaslavska; Inna Grynevych
    Background: The relevance of this topic is due to the increasing incidence of hepatobiliary system in patients infected with SARS-CoV-2. COVID-19-associated hepatitis occurs in 15 - 65% of adult patients and 6 - 27% of children. Aim: To determine the association of hepatobiliary disorders with different variants of SARS-CoV-2 in children with coronavirus infection (COVID-19) who underwent inpatient treatment during a pandemic. Materials and Methods: 945 case histories of children from birth to 17 years of age, who were hospitalized in KCCCIDH in Kyiv, Ukraine with a diagnosis of coronavirus disease in the period from June 2020 to February 2022, were retrospectively studied. Among them were selected cases with elevated bilirubin, ALT and AST. The peculiarities of the results of instrumental and laboratory researches were determined. A distinction was made by age and periods of the pandemic. Statistical software EZR v. 1,54 was used to conduct a statistical study of the obtained results, using the methods of descriptive statistics. Results: An increase in ALT was observed in 8.4% (72/854) cases, an increase in AST in 19% (162/854) patients and an increase in total bilirubin in 3,6% (31/854) patients. In the age structure there was a predominance of all indicators in groups of children from birth to 1 year and age category 1 - 5 years. According to ultrasound, hepatomegaly was registered in 165 (17,5%) with a predominance in children 1 - 5 years, which accounted for 57 (6%) cases. There was a statistically significant increase in ALT and AST during the fourth wave compared to previous outbreaks, p < 0,001. Conclusion: The dependence of transaminase changes on the COVID-19 period in children was revealed. Liver damage may be related to SARS-CoV-2 virus. However, there is still a need for further research to study this relationship in detail and to understand the pathogenetic mechanisms of hepatitis in coronavirus infection in children.
  • No Thumbnail Available
    Item
    Structure of Neurological Complications in Children with Covid-19: A Mini-Review and Own Experience
    (2022-08-16) Sergiy Kramarov; Iryna Seriakova; Vitalii Yevtushenko; Oleksandr Voronov; Oleksandr Buts; Hanna Zaslavska; Inna Grynevych; Natalia Kyzyma
    Aim: Aim of this study was to investigate the features of neurological symptoms in pediatric patients hospitalized during the COVID-19 pandemic in 2020-2022 and to analyze similar symptoms according to the literature. We retrospectively investigated 945 cases of the disease in children aged from birth to 17 years, who were hospitalized in KCCCIDH in Kyiv, Ukraine with a diagnosis of coronavirus in the period from June 2020 to February 2022. Among them, cases with neurological symptoms were analyzed. Peculiarities of the clinical picture and results of laboratory researches were determined. To conduct a statistical study of the results, we used the statistical package Statistical software EZR v. 1.54. Results: Neurological symptoms were observed in 142 (15%) patients. Of these, the most numerous was the group of children aged 10 to 18 years, was 55.6% (79/142). The leading neurological symptoms in children were headache (11.7%), ageusia, anosmia (7%), convulsive syndrome (1.2%), acute polyneuropathy (1.2%) and myalgia/arthralgia (3.7%). Among the laboratory data, we found prognostic value for the appearance of neurological symptoms in leukocytes (0.706; 95% CI 0.443-1.124), C-reactive protein (0.708; 95% CI 0.410-1.220) and procalcitonin (0.33; 95% CI 0.21-0.47). Conclusion: Neurological symptoms are a common manifestation in children in the acute period of coronavirus disease. Further monitoring and control studies are needed to cover the acute onset of neurological symptoms, the results of the neurological examination, the rate of progression and the long-term consequences of nervous system disorders in children with COVID-19.